Clinical trial Recruiting at 1 site Interventional Ages 60 to 85

Personalized lab and home balance training to reduce fall risk in older adults

Official title: Assessment of Fall Risks and Subject-specific Training for Fall Reduction

Run by University of Maryland, Baltimore · NCT06396650 · Data updated 2026-11-12

This program will try individualized lab-based perturbation training plus home exercises to reduce falls in older adults who have fallen before or walk with instability.

More Fall Risk trials

Quick facts

Study typeInterventional
Ages60 Years to 85 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Maryland, Baltimore
Academic / other
Drugs / interventionscart
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedApril 30, 2029
Study endsApril 30, 2029
Registry record updatedFebruary 10, 2026
Trial IDNCT06396650 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Older adults aged 60–85 who can walk independently, have had one or more falls in the past 12 months or report walking instability, and have a family member at home for safety are ideal candidates.

Probably not a fit

People with severe lower-limb pain, recent myocardial infarction, significant cognitive impairment, body weight over 280 lbs, or who are already in another lower-limb rehabilitation program are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Forty adults aged 60–85 with a history of one or more falls or gait instability will be enrolled and tested for fall mechanisms using moving footplates. Investigators will design a subject-specific training plan that includes one supervised session per week in the lab using a sliding stepping perturbation system and three home exercise sessions per week for six weeks. Participants will undergo biomechanical and clinical evaluations before and after the 6-week program and again two months later, and a harness will be used during in-lab perturbation sessions for safety. Common exclusions include severe lower-limb pain, recent myocardial infarction, cognitive impairment (MMSE <25), enrollment in other lower-limb rehab, or body weight over 280 lbs.

Why it matters

Potential benefit: If successful, the program could lower the frequency or severity of falls and help participants maintain mobility and independence.

How similar studies have gone: Previous perturbation-based and balance training programs have shown promise in reducing fall risk in older adults, so this approach builds on existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 60 to 85 years old
2. Have a family member at home for safety.
3. There is no severe injury or pain at the lower extremities.
4. With one or more falls in the past 12 months or walk with instability
5. Individuals who are taking medication, there should be no planned medication changes for the study duration of 3.5 months.
6. All the participants should be capable of independent walking.

Exclusion Criteria:

1. Enrollment in another lower limb rehabilitation program;
2. severe pain in the lower limbs;
3. previous myocardial infarction
4. Body weight over 280 lbs
5. Cognitive impairment (Mini-Mental Status Examination (MMSE) score less than 25)

Where it's running

  • University of Maryland Baltimore
    Baltimore, Maryland, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.